Patent 12527771
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Takeda Pharmaceutical Co Ltd
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
There are no AIA trial proceedings on file for US patent 12527771 as of the most recent ingest. No web search results were found for any additional or older proceedings. This means the patent's claims remain untested by AIA trial proceedings, offering no immediate defensive posture based on PTAB invalidation.
Strategic summary
All claims of US12527771 are currently untested by AIA trial proceedings. This means that a defendant being asserted against still has all prior-art grounds available for challenging the patent's validity, as no estoppel has been triggered under § 315(e)(2). The absence of PTAB activity could suggest several things: the patent is relatively new, it hasn't been heavily asserted yet, or potential challengers have opted for other avenues to address its validity.
Recommended next steps
As there is no PTAB activity for US patent 12527771, a defendant facing assertion of this patent would need to initiate a new AIA trial proceeding if they wish to challenge its validity at the PTAB.
Generated 5/30/2026, 6:45:55 PM